Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. response to covid
Show results for
Products
Services
Training

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Response To Covid Articles & Analysis

52 news found

Clinical Trial Design Trends for 2023

Clinical Trial Design Trends for 2023

About the webinar 2020/21 led to significant clinical trial innovation in clinical trials in response to the Covid-19 pandemic with 2022 providing key insights, projects and lessons in the wider clinical trials space. 2023 will see these lessons merge with long-term trends and the lessons from important pilot programs to see wider use of innovative designs and ...

ByStatsol


Virusight Diagnostic Integrated into Sheba Medical Center’s Battle vs. COVID-19

Virusight Diagnostic Integrated into Sheba Medical Center’s Battle vs. COVID-19

Founded in 2020 in response to the COVID-19 pandemic, Virusight, which is an AI software company, was created to develop an accurate, real-time virus diagnosis solution. ...

ByVirusight


Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination

Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination

Many factors could cause actual future events to differ materially from the forward-looking statements in this communication, including but not limited to: (i) the risk that the proposed Transaction may not be completed in a timely manner or at all, which may adversely affect the price of Aesther’s securities; (ii) the risk that the proposed Transaction may not be completed by ...

ByOcean Biomedical


Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.

Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.

Many factors could cause actual future events to differ materially from the forward-looking statements in this communication, including but not limited to: (i) the risk that the proposed Transaction may not be completed in a timely manner or at all, which may adversely affect the price of Aesther’s securities; (ii) the risk that the proposed Transaction may not be completed by ...

ByOcean Biomedical


Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital

Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital

Many factors could cause actual future events to differ materially from the forward-looking statements in this communication, including but not limited to: (i) the risk that the proposed Transaction may not be completed in a timely manner or at all, which may adversely affect the price of Aesther’s securities; (ii) the risk that the proposed Transaction may not be completed by ...

ByOcean Biomedical


Micropore, Inc. 2020 Champion of Maryland Manufacturing

Micropore, Inc. 2020 Champion of Maryland Manufacturing

SCALING PRODUCTION IN RESPONSE TO THE CHALLENGES OF COVID-19 Micropore. Inc. located in Elkton. ...

BySpiraLith Brand of Micropore, Inc.


Data making a difference: the world-leading data bank behind life-changing research

Data making a difference: the world-leading data bank behind life-changing research

SAIL data has been used widely in a range of research studies focusing on health and wellbeing, including COVID-19 vaccines/treatments, the impact of air pollution, dementia, epilepsy, cystic fibrosis and asthma. ...

ByMediWales


Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data from COVAXIN (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS

Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data from COVAXIN (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS

“The results suggest that COVAXIN™, which is made on the same platform used in traditional polio pediatric vaccines for decades, when administered in a two-dose series to children between 2-18, may offer an option that is safe while delivering a robust immune response.” In the study, immunogenicity against key COVID-19 proteins was measured ...

ByOcugen, Inc.


YourBio Health launches nearly painless, at-home COVID-19 antibody test

YourBio Health launches nearly painless, at-home COVID-19 antibody test

YourBio Health, formerly Seventh Sense Biosystems, Inc., developers of the world’s first push-button blood collection device, announced the launch of its website where UK consumers can order a convenient, easy to use, nearly painless and accurate COVID-19 antibody test. “We’re happy to launch our COVID-19 antibody test service to UK consumers ...

BySeventh Sense Biosystems Inc.


Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

The collaboration will initially focus on developing broad-spectrum Coronavirus agents (e.g., SARS-CoV-2 and its variants, MERS), including accelerating Exscientia’s lead program, which targets the main protease (Mpro) of SARS-CoV-2, the virus responsible for COVID-19. Subsequently, the collaboration will expand to develop therapeutics for influenza and ...

ByExscientia


InspireMD Announces Strong Second Quarter 2021 Financial Results

InspireMD Announces Strong Second Quarter 2021 Financial Results

This increase was primarily due to increases of $705,000 in salary expenses and related accrual expenses mainly driven by temporary salary reductions during the three months ended June 30, 2020, that were implemented in response to the COVID-19 effect on revenues as well as additional resources mainly in our product development and sales infrastructure, $437,000 ...

ByInspireMD Inc.


Aerogen leading the way for inhaled COVID-19 vaccine delivery

Aerogen leading the way for inhaled COVID-19 vaccine delivery

Company’s aerosol drug delivery technology used in Phase 1 clinical trial to deliver inhaled type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults without COVID-19 from China The Aerogen Solo is a closed-system, single-patient-use aerosol drug delivery technology1 that mitigates the transmission of patient-generated infectious aerosol during ...

ByAerogen


Kephera Diagnostics launches CLIA test for quantitative antibody response to COVID-19 vaccination

Kephera Diagnostics launches CLIA test for quantitative antibody response to COVID-19 vaccination

Kephera’s COVI-QUANT™ test measures the level of IgG antibodies to the spike protein, a viral component which is the key antigen in current COVID-19 vaccines. The test will enable individuals to assess their immune response to vaccination or to infection, and to monitor their antibody level for changes over time. At this point, the duration of ...

ByKephera Diagnostics, LLC


Alaska Airlines Partners with AZOVA to Provide Ellume COVID-19 Home Tests & Video Observation for Safe, Healthy Travel

Alaska Airlines Partners with AZOVA to Provide Ellume COVID-19 Home Tests & Video Observation for Safe, Healthy Travel

AZOVA Inc., creator of the world’s most comprehensive digital health network for COVID-19 testing and vaccination management, and Ellume, the company to bring the first non-prescription over-the-counter COVID-19 home test to market, today announced an official partnership with Alaska Airlines to provide a convenient, at-home rapid testing solution for its passengers. The Ellume COVID-19 ...

ByEllume Limited


Ohio Launches COVID-19 Screening Program for K-12 Students and Staff

Ohio Launches COVID-19 Screening Program for K-12 Students and Staff

A new K-12 screening pilot, initiated by Ohio Governor Mike DeWine and administered by Thermo Fisher Scientific and Color Health, will provide testing to students, teachers and staff for COVID-19 on a weekly basis to help ensure safer in-person learning. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Statistics show: the risk of catching the coronavirus from surfaces is low

Statistics show: the risk of catching the coronavirus from surfaces is low

When the coronavirus began spreading around the world, people started to disinfect surfaces and wash their hands more often. During the early days of the pandemic, headlines told us the virus could survive even for days on surfaces and therefore surfaces could be potential sources of infection. Also, health institutions were recommending people to disinfect surfaces to prevent virus transmission. ...

ByGenano Industrial Air Purification Solutions - Genano Ltd.


Thermo Fisher Scientific Launches In-Air SARS-CoV-2 Surveillance Solution

Thermo Fisher Scientific Launches In-Air SARS-CoV-2 Surveillance Solution

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


AcuPebble SA100 joins the NHS Innovation Accelerator 2021

AcuPebble SA100 joins the NHS Innovation Accelerator 2021

This year, the NIA’s rigorous, multi-stage selection process focused on finding evidence-based innovations to address the key NHS priorities of supporting the workforce, mental health and COVID-19 response. As a small wearable device which can be posted to patients and then used unsupervised at home, AcuPebble SA100 addresses the current pressing need for ...

ByAcurable Limited


What We Can Learn from the Spanish Flu

What We Can Learn from the Spanish Flu

As the world reels from the recent impact of COVID-19, researchers are examining ways that the past can inform current and future pandemic response. ...

ByEnGen Bio LLC


Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response

Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response

A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method is comparable to the long-established blood-based method (ABG) of measuring pulmonary gas exchange efficiency. Published in the American Journal of Physiology Lung Cellular and Molecular Physiology, the study, entitled “Measuring the ...

ByMediPines

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT